Advanced Biomatrix Launches CytoSoft® T-Flasks to Revolutionize Cell Culture

CARLSBAD, Calif. -- Advanced BioMatrix launches CytoSoft® T-25 and T-75 Flasks to completely upend traditional cell culture and cell expansion. CytoSoft® flasks contain a thin layer of biocompatible silicone formulated to a specific stiffness including 0.2, 0.5, 2, 8, 16, 32, and 64 kPa. This range of stiffness mimics the human body – from the [...]

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year

SANTA CLARA, Calif. --  Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace. Specifically, Agilent ranked No. 83 out of 500 companies on Forbes’s 2021 list of America’s Best Employers for Diversity. [...]

tec5 AG Strengthens Management Board

Nikolaus Petzold has held the newly created position of Sales and Marketing Director at tec5 AG since April 1, 2021. The expansion of the Management Board thus takes into account the sustained positive development of the tec5 group. Petzold, a physicist, brings with him several years of experience in sales and marketing from the EMS [...]

High Recovery of Top-Quality Purified RNA

Porvair Sciences has launched new kits for rapid extraction of total RNA from a wide range of biological samples. These proprietary kits enable extraction of up to 1000 µg of application-ready pure RNA in as little as 10 minutes. Extraction and purification of  RNA is required for numerous downstream molecular biology applications such as RT-PCR, [...]

Tosoh Bioscience Introduces TSKgel® FcR-IIIA-5PW HPLC Column

Fraction Collection of Antibodies with Different FcR Affinities for Characterization King of Prussia, PA - Tosoh Bioscience LLC, a provider of chromatographic solutions for the separation of biomolecules, announced today the introduction of its TSKgel FcR-IIIA-5PW® HPLC column. This column is the second in the FcRγ affinity chromatography portfolio for antibody drug analysis developed independently by Tosoh Corporation. [...]

MacroGenics Adopts Genedata Profiler to Enhance Development of Immunotherapies

Emerging leader in immuno-oncology therapeutics implements innovative software platform to design smarter clinical trials and accelerate development of precision medicines Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a long-term partnership agreement with MacroGenics, a biopharmaceutical company and an emerging leader in developing and commercializing innovative immune-oncology [...]

ERS Genomics and NUVISAN ICB sign CRISPR/Cas9 license agreement

CRISPR offerings to enhance NUVISAN’s drug development service portfolio Dublin, Ireland and Berlin, Germany: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and NUVISAN Innovation Campus Berlin (ICB) GmbH, a fully integrated contract research service provider for drug discovery and early development programs, [...]

Axion BioSystems Announces Formation of Scientific Advisory Board

Members include experts in neurobiology, stem cell biology, immuno-oncology, personalized medicine, and virology Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells in vitro, announces the formation of a Scientific Advisory Board (SAB). The SAB will be chaired by Jim Ross, Ph.D., founder [...]

Sartorius Expands in the UK By Relocating to a New Facility for Downstream Processing Equipment

New 58,000-square-foot facility will simplify and accelerate the production of downstream processing equipment, including chromatography technologies and time- and cost-saving tangential flow filtration Dedicated space for demonstration and factory acceptance testing of instruments and systems HAVANT, UK -- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will open a new state-of-the-art manufacturing [...]

Twist Bioscience to Expand Oregon Lease, Supporting Future Growth

SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has exercised its right of first refusal to expand the lease for its “Factory of the Future” manufacturing facility near Portland, Oregon. The expanded [...]

Access IBO on Knowledge Center